Thomas Meergans

485 total citations
14 papers, 397 citations indexed

About

Thomas Meergans is a scholar working on Molecular Biology, Epidemiology and Genetics. According to data from OpenAlex, Thomas Meergans has authored 14 papers receiving a total of 397 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Epidemiology and 3 papers in Genetics. Recurrent topics in Thomas Meergans's work include Cell death mechanisms and regulation (4 papers), Genomics and Chromatin Dynamics (4 papers) and Immune Response and Inflammation (3 papers). Thomas Meergans is often cited by papers focused on Cell death mechanisms and regulation (4 papers), Genomics and Chromatin Dynamics (4 papers) and Immune Response and Inflammation (3 papers). Thomas Meergans collaborates with scholars based in Germany, Austria and Switzerland. Thomas Meergans's co-authors include Detlef Doenecke, Werner Albig, Albrecht Wendel, Hannes Hentze, Gisa Tiegs, Gerald Künstle, Paul‐Georg Germann, Martin Kratzmeier, Thomas Härtung and Carolin Rauter and has published in prestigious journals such as The Journal of Immunology, Hepatology and Biochemical Journal.

In The Last Decade

Thomas Meergans

14 papers receiving 375 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Thomas Meergans Germany	11	247	81	45	38	37	14	397
Zeev Zaslavsky Israel	9	209 0.8×	117 1.4×	39 0.9×	32 0.8×	93 2.5×	12	406
Sha Zhu China	13	142 0.6×	53 0.7×	65 1.4×	62 1.6×	58 1.6×	24	323
Robin Mukhopadhyaya India	9	202 0.8×	135 1.7×	132 2.9×	51 1.3×	48 1.3×	18	472
Luhui Shen United States	10	180 0.7×	88 1.1×	23 0.5×	51 1.3×	19 0.5×	23	384
Daisy Hjelmqvist Sweden	7	206 0.8×	107 1.3×	34 0.8×	23 0.6×	52 1.4×	12	399
Baher Nashed Canada	7	124 0.5×	190 2.3×	30 0.7×	41 1.1×	18 0.5×	7	412
Maryline Roy France	11	268 1.1×	101 1.2×	57 1.3×	44 1.2×	42 1.1×	20	461
Heather S. Kain United States	9	113 0.5×	73 0.9×	71 1.6×	64 1.7×	36 1.0×	12	373
Elena Valente Italy	12	93 0.4×	110 1.4×	29 0.6×	24 0.6×	38 1.0×	22	409
Sanja Vodanovic‐Jankovic United States	12	147 0.6×	289 3.6×	33 0.7×	59 1.6×	24 0.6×	14	568

Countries citing papers authored by Thomas Meergans

Since Specialization

Citations

This map shows the geographic impact of Thomas Meergans's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas Meergans with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas Meergans more than expected).

Fields of papers citing papers by Thomas Meergans

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Thomas Meergans. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas Meergans. The network helps show where Thomas Meergans may publish in the future.

Co-authorship network of co-authors of Thomas Meergans

This figure shows the co-authorship network connecting the top 25 collaborators of Thomas Meergans. A scholar is included among the top collaborators of Thomas Meergans based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Thomas Meergans. Thomas Meergans is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

1.

Sigel, Stefanie, Sebastian Bunk, Thomas Meergans, et al.. (2012). Apolipoprotein B100 is a suppressor of Staphylococcus aureus‐induced innate immune responses in humans and mice. European Journal of Immunology. 42(11). 2983–2989. 17 indexed citations

2.

Rauter, Carolin, Markus S. Mueller, Isabel Diterich, et al.. (2005). Critical Evaluation of Urine-Based PCR Assay for Diagnosis of Lyme Borreliosis. Clinical and Vaccine Immunology. 12(8). 910–917. 37 indexed citations

3.

Röhrig, Christoph H., et al.. (2004). In vitro non-natural amino acid mutagenesis using a suppressor tRNA generated by the cis-acting hepatitis delta virus ribozyme. Biochemical and Biophysical Research Communications. 325(3). 731–738. 2 indexed citations

4.

Künstle, Gerald, et al.. (2004). Activation of Caspases in HepG2 Cells is Dispensable for Cytokine-mediated Apoptosis Induced by either TNF, TRAIL or Agonistic anti-CD95 Antibody. Zeitschrift für Gastroenterologie. 42(1). 1 indexed citations

5.

Xu, Jian, Rudolf Lucas, Marcus Schuchmann, et al.. (2003). GM-CSF Restores Innate, But Not Adaptive, Immune Responses in Glucocorticoid-Immunosuppressed Human Blood In Vitro. The Journal of Immunology. 171(2). 938–947. 22 indexed citations

6.

Hareng, Lars, Thomas Meergans, Sonja von Aulock, Hans‐Dieter Volk, & Thomas Härtung. (2003). Cyclic AMP increases endogenous granulocyte colony‐stimulating factor formation in monocytes and THP‐1 macrophages despite attenuated TNF‐α formation. European Journal of Immunology. 33(8). 2287–2296. 15 indexed citations

7.

Meergans, Thomas, et al.. (2000). The short prodomain influences caspase-3 activation in HeLa cells. Biochemical Journal. 349(1). 135–135. 35 indexed citations

8.

Meergans, Thomas, et al.. (2000). The short prodomain influences caspase-3 activation in HeLa cells. Biochemical Journal. 349(1). 135–140. 26 indexed citations

9.

Künstle, Gerald, Hannes Hentze, Paul‐Georg Germann, et al.. (1999). Concanavalin A hepatotoxicity in mice: Tumor necrosis factor-mediated organ failure independent of caspase-3-like protease activation. Hepatology. 30(5). 1241–1251. 82 indexed citations

10.

Kratzmeier, Martin, Werner Albig, Thomas Meergans, & Detlef Doenecke. (1999). Changes in the protein pattern of H1 histones associated with apoptotic DNA fragmentation. Biochemical Journal. 337(2). 319–319. 10 indexed citations

11.

Kratzmeier, Martin, Werner Albig, Thomas Meergans, & Detlef Doenecke. (1999). Changes in the protein pattern of H1 histones associated with apoptotic DNA fragmentation. Biochemical Journal. 337(2). 319–327. 29 indexed citations

12.

Meergans, Thomas, Werner Albig, & Detlef Doenecke. (1998). Conserved sequence elements in human main type‐H1 histone gene promoters : their role in H1 gene expression. European Journal of Biochemistry. 256(2). 436–446. 20 indexed citations

13.

Albig, Werner, Thomas Meergans, & Detlef Doenecke. (1997). Characterization of the H1.5 gene completes the set of human H1 subtype genes. Gene. 184(2). 141–148. 50 indexed citations

14.

Meergans, Thomas, Werner Albig, & Detlef Doenecke. (1997). Varied Expression Patterns of Human H1 Histone Genes in Different Cell Lines. DNA and Cell Biology. 16(9). 1041–1049. 51 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact